MSH2 and Lynch syndrome: Taken together, reports indicate that at least some minor fraction within large populations of UC patients are expected to carry Lynch syndrome (or associated) neoplasms and should be checked for MLH1, MSH2, MSH6, and PMS2 mutations [11].